Healthcare Services

Global Low-Density Lipoprotein Test Market Analysis (2026–2030) With Strategic Insights

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Low-Density Lipoprotein Test Market From 2026 To 2030?

The low-density lipoprotein test market has experienced strong growth in recent years. It is anticipated to expand from $8.83 billion in 2025 to $9.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.5%. This historic growth can be linked to factors like the increasing prevalence of cardiovascular diseases, the early clinical reliance on ldl-c testing, a rising incidence of obesity and diabetes, the expansion of hospital-based diagnostic laboratories, and growing awareness of cholesterol management.

The low-density lipoprotein test market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $11.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. Several factors are driving this growth during the forecast period, including an increased emphasis on preventive healthcare, a rise in screening for dyslipidaemia, the expanding adoption of advanced lipid testing techniques, a growing need for early detection of stroke and heart disease risks, and elevated healthcare expenditure on diagnostic services. Key developments expected in this period encompass a heightened focus on preventive cardiovascular screening, the increasing utilization of comprehensive lipid panel testing, a surge in demand for regular cholesterol monitoring, the broader application of LDL testing in managing metabolic disorders, and the growing uptake of point-of-care lipid testing solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp

Which Factors Are Influencing The Growth Of The Low-Density Lipoprotein Test Market?

The increasing occurrence of cardiovascular diseases is anticipated to fuel the expansion of the low-density lipoprotein test market moving ahead. These diseases encompass conditions impacting the heart or blood vessels. The low-density lipoprotein test serves in the management of cardiovascular diseases through direct measurement of low-density lipoprotein levels in the heart. As an illustration, figures from February 2024, reported by the UK Parliament, a UK-based governing body, indicate that heart and circulatory diseases are responsible for approximately 25% of all deaths in England, leading to over 140,000 fatalities yearly and roughly 480 daily, equating to one death every three minutes. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the low-density lipoprotein test market.

How Are Different Segments Classified In The Low-Density Lipoprotein Test Market Segment Analysis?

The low-density lipoprotein test market covered in this report is segmented –

1) By Product Type: Low-Density Lipoprotein Cholesterol (LDL-C), Low-Density Lipoprotein Particle Number (LDL-P), Low-Density Lipoprotein Particle Size (LDL-B), Other Product Types

2) By Component: Kits, Reagents, Devices, Other Components

3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types

4) By Distribution Channel: Direct Tenders, Retail

5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users

Subsegments:

1) By Low-Density Lipoprotein Cholesterol (LDL-C): Direct Measurement Tests, Calculated LDL-C Tests

2) By Low-Density Lipoprotein Particle Number (LDL-P): NMR (Nuclear Magnetic Resonance) Tests, Other Particle Counting Methods

3) By Low-Density Lipoprotein Particle Size (LDL-B): Gradient Gel Electrophoresis, Other Size Measurement Techniques

4) By Other Product Types: Lipid Panel Tests: Genetic Testing For Dyslipidemia, Point-Of-Care Testing Devices

Which Trends Are Influencing Demand In The Low-Density Lipoprotein Test Market?

Major companies operating in the low-density lipoprotein (LDL) test market are prioritizing the introduction of innovative diagnostic solutions, such as advanced lipoprotein analysis systems, to enhance cardiovascular risk assessment, diagnostic accuracy, and patient management. These advanced lipoprotein analysis systems leverage technologies like nuclear magnetic resonance (NMR) spectroscopy and algorithm-driven interpretation to offer deeper insights into lipid profiles beyond standard LDL-C measurements, improving clinical decision-making for individuals with cardiometabolic risks. For instance, in July 2023, Numares Health, a Germany-based health diagnostic company, launched the AXINON LDL-p Test System. This FDA-cleared diagnostic tool provides a more detailed assessment of lipoproteins, offering insights into cardiac function that extend beyond standard LDL-C measurements. Utilizing nuclear magnetic resonance (NMR) spectroscopy, the system incorporates advanced diagnostic algorithms to boost accuracy. It assists physicians in better managing patients at elevated risk for cardiovascular disease, particularly those with cardiometabolic risk factors.

Who Are The Companies Driving Activity In The Low-Density Lipoprotein Test Market?

Major companies operating in the low-density lipoprotein test market are Abbott Laboratories, Siemens Healthineers, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, DiaSorin SpA, Randox Laboratories Ltd, Sekisui Diagnostics, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc, OPKO Health Inc, Merck KGaA, Agilent Technologies Inc, Becton Dickinson and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Home Access Health Corporation

Get The Full Low-Density Lipoprotein Test Market Report:

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Which Region Is The Largest In The Low-Density Lipoprotein Test Market?

North America was the largest region in the Low-Density Lipoprotein Test market in 2025. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Low-Density Lipoprotein Test Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Browse Through More Reports Similar to the Global Low-Density Lipoprotein Test Market 2026, By The Business Research Company

Cholesterol Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Lipid Panel Testing Market Report

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Poc Cholesterol Test Market

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795